First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone
Synthetic cannabinoids- (SCs-) induced psychosis is a growing public health concern. It leads to significant impairment, including emotional distress, difficulty communicating, and other debilitating symptoms. In this case report, we discuss a patient with no previous history of psychotic symptoms,...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Case Reports in Psychiatry |
| Online Access: | http://dx.doi.org/10.1155/2016/7257489 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832551138934652928 |
|---|---|
| author | Aaron J. Roberto Aileen Lorenzo Kevin J. Li Jonathan Young Abhishek Mohan Subhash Pinnaka Kyle A. B. Lapidus |
| author_facet | Aaron J. Roberto Aileen Lorenzo Kevin J. Li Jonathan Young Abhishek Mohan Subhash Pinnaka Kyle A. B. Lapidus |
| author_sort | Aaron J. Roberto |
| collection | DOAJ |
| description | Synthetic cannabinoids- (SCs-) induced psychosis is a growing public health concern. It leads to significant impairment, including emotional distress, difficulty communicating, and other debilitating symptoms. In this case report, we discuss a patient with no previous history of psychotic symptoms, presenting with first-episode psychosis in the context of progressive, acutely worsening, disorganized, psychotic thoughts and behaviors following prolonged use of SCs. We also discuss relevant literature on SCs-induced psychosis, highlighting its prevalence, presentation, diagnosis, and recommended management. It is important to diagnose and treat SCs-induced psychosis as early and efficiently as possible, in order to alleviate symptoms while limiting functional impairment and emotional distress to the patient. |
| format | Article |
| id | doaj-art-b5dddc55ebff4a6d9e5990ff3ec2d54c |
| institution | Kabale University |
| issn | 2090-682X 2090-6838 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Psychiatry |
| spelling | doaj-art-b5dddc55ebff4a6d9e5990ff3ec2d54c2025-02-03T06:04:58ZengWileyCase Reports in Psychiatry2090-682X2090-68382016-01-01201610.1155/2016/72574897257489First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and RisperidoneAaron J. Roberto0Aileen Lorenzo1Kevin J. Li2Jonathan Young3Abhishek Mohan4Subhash Pinnaka5Kyle A. B. Lapidus6Child and Adolescent Psychiatry, Boston Children’s Hospital, Harvard Medical School, 300 Longwood Avenue, Fegan 8, Boston, MA 02115, USAAdult Psychiatry, New York Medical College, Valhalla, NY, USAAdult Psychiatry, Harvard South Shore Psychiatry, Brockton, MA, USADuke University School of Medicine, Durham, NC, USAOld Dominion University, Norfolk, VA, USAAdult Psychiatry, New York Medical College, Valhalla, NY, USANorthwell Health, Zucker Hillside Hospital, Glen Oaks, NY, USASynthetic cannabinoids- (SCs-) induced psychosis is a growing public health concern. It leads to significant impairment, including emotional distress, difficulty communicating, and other debilitating symptoms. In this case report, we discuss a patient with no previous history of psychotic symptoms, presenting with first-episode psychosis in the context of progressive, acutely worsening, disorganized, psychotic thoughts and behaviors following prolonged use of SCs. We also discuss relevant literature on SCs-induced psychosis, highlighting its prevalence, presentation, diagnosis, and recommended management. It is important to diagnose and treat SCs-induced psychosis as early and efficiently as possible, in order to alleviate symptoms while limiting functional impairment and emotional distress to the patient.http://dx.doi.org/10.1155/2016/7257489 |
| spellingShingle | Aaron J. Roberto Aileen Lorenzo Kevin J. Li Jonathan Young Abhishek Mohan Subhash Pinnaka Kyle A. B. Lapidus First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone Case Reports in Psychiatry |
| title | First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone |
| title_full | First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone |
| title_fullStr | First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone |
| title_full_unstemmed | First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone |
| title_short | First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone |
| title_sort | first episode of synthetic cannabinoid induced psychosis in a young adult successfully managed with hospitalization and risperidone |
| url | http://dx.doi.org/10.1155/2016/7257489 |
| work_keys_str_mv | AT aaronjroberto firstepisodeofsyntheticcannabinoidinducedpsychosisinayoungadultsuccessfullymanagedwithhospitalizationandrisperidone AT aileenlorenzo firstepisodeofsyntheticcannabinoidinducedpsychosisinayoungadultsuccessfullymanagedwithhospitalizationandrisperidone AT kevinjli firstepisodeofsyntheticcannabinoidinducedpsychosisinayoungadultsuccessfullymanagedwithhospitalizationandrisperidone AT jonathanyoung firstepisodeofsyntheticcannabinoidinducedpsychosisinayoungadultsuccessfullymanagedwithhospitalizationandrisperidone AT abhishekmohan firstepisodeofsyntheticcannabinoidinducedpsychosisinayoungadultsuccessfullymanagedwithhospitalizationandrisperidone AT subhashpinnaka firstepisodeofsyntheticcannabinoidinducedpsychosisinayoungadultsuccessfullymanagedwithhospitalizationandrisperidone AT kyleablapidus firstepisodeofsyntheticcannabinoidinducedpsychosisinayoungadultsuccessfullymanagedwithhospitalizationandrisperidone |